Physician Assistant · Madera, CA
NPI
1588698112
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
451 E Almond Ave, Suite 103
Madera, CA, 93637
Phone (559) 673-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
243 services
Medicare patients, 2024
223
Average age 69
Drug cost, 2024
$3.5M
2,642 prescriptions
Company payments, 2025
$286K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mikhail Alper was code 99204 (office e&m - new), 125 times for 125 patients. In total Mikhail Alper billed 243 services in 10 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99204 Office E&M - New | Office | 125 | 125 | $101.91 | $13K |
| 99214 Office E&M - Established | Office | 57 | 51 | $74.05 | $4,221 |
| 99203 Office E&M - New | Office | 27 | 27 | $65.19 | $1,760 |
| 99213 Office E&M - Established | Office | 16 | 15 | $61.26 | $980 |
By year: 2023 $29K for 434 services; 2024 $21K for 243 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mikhail Alper prescribed most often to Medicare patients was Famotidine, with 399 prescriptions and refills. In total Mikhail Alper wrote 2,642 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 399 | 1,102 | 197 | $9,754 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 332 | 332 | 314 | $5,182 |
| Omeprazole Generic | 274 | 744 | 116 | $3,592 |
| Pantoprazole Sodium Generic | 196 | 525 | 73 | $2,940 |
| Linzess Linaclotide | 158 | 312 | 73 | $171K |
| Ursodiol Generic | 140 | 321 | 49 | $28K |
| Zenpep Lipase/Protease/Amylase | 130 | 178 | 50 | $702K |
| Creon Lipase/Protease/Amylase | 103 | 128 | 36 | $313K |
| Xifaxan Rifaximin | 96 | 102 | 31 | $329K |
| Furosemide Generic | 80 | 88 | 18 | $287 |
| Spironolactone Generic | 73 | 88 | 18 | $809 |
| Voquezna Vonoprazan Fumarate | 54 | 58 | 22 | $36K |
| Lactulose Generic | 45 | 58 | 15 | $1,560 |
| Vemlidy Tenofovir Alafenamide | 36 | 36 | Under 11 | $52K |
| Sucralfate Generic | 31 | 71 | 12 | $2,489 |
Brand drugs: 870 claims; generic drugs: 1,772 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mikhail Alper $286K ($286K in general payments such as food, travel and fees) from 24 companies. The largest payer was Janssen Biotech, Inc. with $78K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 124 | $78K |
| Abbvie Inc. ABBV | 135 | $42K |
| Aimmune Therapeutics, Inc. | 77 | $27K |
| Madrigal Pharmaceuticals MDGL | 66 | $25K |
| Gilead Sciences, Inc. GILD | 51 | $23K |
| Regeneron Healthcare Solutions, Inc. REGN | 42 | $22K |
| Lilly USA, LLC LLY | 23 | $16K |
| Genzyme Corporation SNY | 20 | $15K |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 32 | $12K |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 99 | $6,922 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.